MapLight Therapeutics, Inc. MPLT Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's accretion (amortization) of discounts and premiums, investments?
- MapLight Therapeutics, Inc. (MPLT) reported accretion (amortization) of discounts and premiums, investments of $814K in Q1 2026.
- What does accretion (amortization) of discounts and premiums, investments mean?
- This represents the non-cash adjustment to net income resulting from the amortization of premiums or accretion of discounts on debt securities held as investments. It reflects the gradual adjustment of the carrying value of investment assets toward their face value over time. This metric is essential for reconciling net income with actual cash flows generated from investment activities.